Spots Global Cancer Trial Database for acute lymphoblastic leukemia with failed remission
Every month we try and update this database with for acute lymphoblastic leukemia with failed remission cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO) | NCT03751072 | Acute Lymphobla... Acute Lymphobla... | 18 Years - | Group for Research in Adult Acute Lymphoblastic Leukemia | ||
| Venetoclax Basket Trial for High Risk Hematologic Malignancies | NCT05292664 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ... | Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag... | 1 Year - 40 Years | Dana-Farber Cancer Institute | |
| CAR-T Cell Therapy Targeting to CD19 for R/R ALL | NCT03919240 | Acute Lymphobla... | CAR T-cell ther... | - | The First Affiliated Hospital of Soochow University | |
| Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL | NCT05779930 | Acute Lymphobla... Non-Hodgkin's L... Non-Hodgkin's L... Acute Lymphobla... B-cell Non Hodg... B Cell Leukemia | CD19 specific C... | - 30 Years | Nationwide Children's Hospital | |
| CAR-T Cell Therapy Targeting to CD19 for R/R ALL | NCT03919240 | Acute Lymphobla... | CAR T-cell ther... | - | The First Affiliated Hospital of Soochow University | |
| Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL | NCT05779930 | Acute Lymphobla... Non-Hodgkin's L... Non-Hodgkin's L... Acute Lymphobla... B-cell Non Hodg... B Cell Leukemia | CD19 specific C... | - 30 Years | Nationwide Children's Hospital | |
| Determining the Mechanisms of Loss of CAR T Cell Persistence | NCT05809284 | Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... | - 25 Years | University College, London | ||
| Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO) | NCT03751072 | Acute Lymphobla... Acute Lymphobla... | 18 Years - | Group for Research in Adult Acute Lymphoblastic Leukemia | ||
| Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia | NCT06034561 | Acute Lymphobla... Acute Lymphobla... | Bortezomib | 16 Years - 60 Years | Instituto do Cancer do Estado de São Paulo | |
| Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO) | NCT03751072 | Acute Lymphobla... Acute Lymphobla... | 18 Years - | Group for Research in Adult Acute Lymphoblastic Leukemia | ||
| Determining the Mechanisms of Loss of CAR T Cell Persistence | NCT05809284 | Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... | - 25 Years | University College, London | ||
| Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL | NCT05779930 | Acute Lymphobla... Non-Hodgkin's L... Non-Hodgkin's L... Acute Lymphobla... B-cell Non Hodg... B Cell Leukemia | CD19 specific C... | - 30 Years | Nationwide Children's Hospital | |
| Venetoclax Basket Trial for High Risk Hematologic Malignancies | NCT05292664 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ... | Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag... | 1 Year - 40 Years | Dana-Farber Cancer Institute | |
| Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia | NCT03515200 | Acute Lymphobla... Acute Lymphobla... | Palbociclib Ora... Intrathecal Tri... Dexamethasone Bortezomib Dasatinib Doxorubicin Ruxolitinib | - 21 Years | St. Jude Children's Research Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
